What We Know and Would Like to Know about CDKL5 and Its Involvement in Epileptic Encephalopathy
In the last few years, the X-linked serine/threonine kinase cyclin-dependent kinase-like 5 (CDKL5) has been associated with early-onset epileptic encephalopathies characterized by the manifestation of intractable epilepsy within the first weeks of life, severe developmental delay, profound hypotonia...
Saved in:
| Main Authors: | Charlotte Kilstrup-Nielsen, Laura Rusconi, Paolo La Montanara, Dalila Ciceri, Anna Bergo, Francesco Bedogni, Nicoletta Landsberger |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2012-01-01
|
| Series: | Neural Plasticity |
| Online Access: | http://dx.doi.org/10.1155/2012/728267 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Characterisation of CDKL5 Transcript Isoforms in Human and Mouse.
by: Ralph D Hector, et al.
Published: (2016-01-01) -
The Effect of SARS-CoV-2 on the Gut and Its Microbiome: What We Know and What We Would Like to Know
by: N. V. Evdokimova, et al.
Published: (2024-01-01) -
Genetic epilepsy caused by CDKL5 gene mutations as an example of epileptic encephalopathy and developmental encephalopathy: literature review and own observations
by: K. Yu. Mukhin, et al.
Published: (2021-07-01) -
What Engineering Sophomores Know and Would Like to Know About Engineering Information Sources and Access.
by: Zorana Ercegovac
Published: (2009-05-01) -
Cultured meat production: what we know, what we don’t know and what we should know
by: Maria Olenic, et al.
Published: (2023-12-01)